Norges Bank Makes New $45.11 Million Investment in Envista Holdings Corporation $NVST

Norges Bank purchased a new position in Envista Holdings Corporation (NYSE:NVST) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 2,078,001 shares of the company’s stock, valued at approximately $45,113,000. Norges Bank owned approximately 1.26% of Envista as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of NVST. Holocene Advisors LP purchased a new stake in shares of Envista during the 2nd quarter worth approximately $43,936,000. Alliancebernstein L.P. raised its holdings in shares of Envista by 34.0% during the 2nd quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after acquiring an additional 1,547,656 shares in the last quarter. Balyasny Asset Management L.P. purchased a new stake in shares of Envista during the 3rd quarter worth approximately $24,260,000. Jupiter Asset Management Ltd. raised its holdings in shares of Envista by 48.2% during the 4th quarter. Jupiter Asset Management Ltd. now owns 1,999,048 shares of the company’s stock worth $43,399,000 after acquiring an additional 650,006 shares in the last quarter. Finally, Integral Health Asset Management LLC purchased a new stake in shares of Envista during the 3rd quarter worth approximately $11,204,000.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Weiss Ratings cut Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Wall Street Zen cut shares of Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Barclays upped their target price on shares of Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a research report on Wednesday, February 11th. Citigroup assumed coverage on shares of Envista in a research report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 target price on the stock. Finally, Evercore reissued an “outperform” rating and issued a $33.00 price objective on shares of Envista in a research report on Thursday, May 7th. Six research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $28.83.

Envista Price Performance

NVST opened at $23.45 on Tuesday. The business’s 50-day moving average is $25.08 and its two-hundred day moving average is $24.61. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06. Envista Holdings Corporation has a 1 year low of $18.25 and a 1 year high of $30.42. The firm has a market capitalization of $3.82 billion, a PE ratio of 57.20, a price-to-earnings-growth ratio of 1.31 and a beta of 0.88.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. The business had revenue of $705.50 million for the quarter, compared to analyst estimates of $680.04 million. During the same period in the previous year, the company earned $0.24 earnings per share. The business’s revenue for the quarter was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Research analysts anticipate that Envista Holdings Corporation will post 1.42 earnings per share for the current fiscal year.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.